Dr. Franz Koehler Chemie GmbH, based in Bensheim (Commercial Register B Darmstadt, HRB 2629), manufactures and distributes chemical-technical and pharmaceutical products. Key revenue drivers are drug groups such as Custodiol, which accounted for TEUR 26,862 or about 59.0% of sales in 2024, as well as Sedalam/Sedalor and Proveblue. The company runs international distribution activities and holds majority stakes in Koehler Pharmaceutical (Beijing) Ltd. (55%) and Koehler Pharmaceutical Asia Pte Ltd. (76%). In fiscal year 2024 the company employed an average of 253 staff, generated sales of TEUR 45,545 and reported a net profit of TEUR 3,016.
Die Herstellung und der Vertrieb von chemisch-technischen und pharmazeutischen Produkten.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 2629 (as of 4 October 2026)
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 2629 (as of 4 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Darmstadt Local Court, HRB 2629 (as of 4 October 2026)
Immunic AG
Gräfelfing · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
ZytoService Deutschland GmbH Leipzig
Leipzig · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Chemische Fabrik Kreussler & Co Gesellschaft mit beschränkter Haftung
Wiesbaden · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Sign in to view detailed salary and cost trends.
